Mark J. Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark J. Zhang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Alexandru Movila
Indiana University School of Dentistry
1 shared publicationAlix Teal
Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine
1 shared publicationAlyson Essex
Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine
1 shared publicationChiaki Yamada
Indiana University School of Dentistry
1 shared publicationDan Horan
Roudebush Veterans Administration Medical Center
1 shared publicationGabriel Ramirez
Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine
1 shared publication
Latest Publications
- Open Access
- 31 December 2024
- Published by IU Indianapolis University Library in Proceedings of IMPRS
- Vol. 7 (1)
Sexual Dimorphism in the Skeleton of Adult and Aged Mice with Alzheimer’s Disease-Related Mutations
Background and Hypothesis: Alzheimer’s disease (AD) is a progressive neurological disease characterized by gradual impairment in cognition and memory. Osteoporosis is another common degenerative disease in aging populations. Recent research has uncovered links between AD and bone biology, as well as potential sex-linked differences in disease progression, but the mechanisms behind this are yet to be fully understood. We hypothesize that at both 4 and 13 months of age, female mice with AD-related mutations will have more age-related adverse effects on bone microstructure and geometry than their male counterparts. Project Methods: Male and female mice expressing humanized forms of AD-linked mutations (Swedish/Artic/Austrian) in the Amyloid Precursor Protein (APP-SAA) were raised until either 4 or 13 months of age to accelerate plaque formation. Dxa/Piximus data was collected for body weight, total bone mineral density (BMD), femur BMD, and spine BMD for both age groups and sexes. Trabecular bone from distal femora and cortical bone from femoral mid-diaphyses were then analyzed by μCT. Sexes were analyzed separately by 2-way ANOVA (Tukey’s post-hoc multiple comparisons) or unpaired t-test. Results: Our results show that among mice with AD-related mutations, female sex is associated with more pronounced age-related effects on bone. Both sexes displayed increases in tissue and marrow area, point of maximal inertia, and tissue mineral density, but females showed a more detrimental effect with age. The deleterious effects of age were more apparent in trabecular bone than cortical, with female APP-SAA mice also displaying significantly lower BV/TV, Tb.N., Tb.Th., and higher Tb.Sp. than male APP-SAA mice at both ages. Conclusion and Potential Impact: AD and osteoporosis are prevalent and debilitating diseases affecting millions of patients throughout the United States. The results from this study will help to understand the relationship between them and identify potential interactions between sex and disease progression.
- 31 December 2024
- Published by IU Indianapolis University Library in Proceedings of IMPRS
- Vol. 7 (1)
Open AccessSexual Dimorphism in the Skeleton of Adult and Aged Mice with Alzheimer’s Disease-Related Mutations
Background and Hypothesis: Alzheimer’s disease (AD) is a progressive neurological disease characterized by gradual impairment in cognition and memory. Osteoporosis is another common degenerative disease in aging populations. Recent research has uncovered links between AD and bone biology, as well as potential sex-linked differences in disease progression, but the mechanisms behind this are yet to be fully understood. We hypothesize that at both 4 and 13 months of age, female mice with AD-related mutations will have more age-related adverse effects on bone microstructure and geometry than their male counterparts. Project Methods: Male and female mice expressing humanized forms of AD-linked mutations (Swedish/Artic/Austrian) in the Amyloid Precursor Protein (APP-SAA) were raised until either 4 or 13 months of age to accelerate plaque formation. Dxa/Piximus data was collected for body weight, total bone mineral density (BMD), femur BMD, and spine BMD for both age groups and sexes. Trabecular bone from distal femora and cortical bone from femoral mid-diaphyses were then analyzed by μCT. Sexes were analyzed separately by 2-way ANOVA (Tukey’s post-hoc multiple comparisons) or unpaired t-test. Results: Our results show that among mice with AD-related mutations, female sex is associated with more pronounced age-related effects on bone. Both sexes displayed increases in tissue and marrow area, point of maximal inertia, and tissue mineral density, but females showed a more detrimental effect with age. The deleterious effects of age were more apparent in trabecular bone than cortical, with female APP-SAA mice also displaying significantly lower BV/TV, Tb.N., Tb.Th., and higher Tb.Sp. than male APP-SAA mice at both ages. Conclusion and Potential Impact: AD and osteoporosis are prevalent and debilitating diseases affecting millions of patients throughout the United States. The results from this study will help to understand the relationship between them and identify potential interactions between sex and disease progression.
- 3 August 2023
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (9) , 1803-1816
Chloroacetamide fragment library screening identifies new scaffolds for covalent inhibition of the TEAD·YAP1 interaction
Transcriptional enhanced associate domain (TEAD) binding to co-activator yes-associated protein (YAP1) leads to a transcription factor of the Hippo pathway. TEADs are regulated by S-palmitoylation of a conserved cysteine located in a deep well-defined hydrophobic pocket outside the TEAD·YAP1 interaction interface. Previously, we reported the discovery of a small molecule based on the structure of flufenamic acid that binds to the palmitate pocket, forms a covalent bond with the conserved cysteine, and inhibits TEAD4 binding to YAP1. Here, we screen a fragment library of chloroacetamide electrophiles to identify new scaffolds that bind to the palmitate pocket of TEADs and disrupt their interaction with YAP1. Time- and concentration-dependent studies with wild-type and mutant TEAD1–4 provided insight into their reaction rates and binding constants and established the compounds as covalent inhibitors of TEAD binding to YAP1. Binding pose hypotheses were generated by covalent docking revealing that the fragments and compounds engage lower, middle, and upper sub-sites of the palmitate pocket. Our fragments and compounds provide new scaffolds and starting points for the design of derivatives with improved inhibition potency of TEAD palmitoylation and binding to YAP1.
- 3 August 2023
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (9) , 1803-1816
Chloroacetamide fragment library screening identifies new scaffolds for covalent inhibition of the TEAD·YAP1 interaction
Transcriptional enhanced associate domain (TEAD) binding to co-activator yes-associated protein (YAP1) leads to a transcription factor of the Hippo pathway. TEADs are regulated by S-palmitoylation of a conserved cysteine located in a deep well-defined hydrophobic pocket outside the TEAD·YAP1 interaction interface. Previously, we reported the discovery of a small molecule based on the structure of flufenamic acid that binds to the palmitate pocket, forms a covalent bond with the conserved cysteine, and inhibits TEAD4 binding to YAP1. Here, we screen a fragment library of chloroacetamide electrophiles to identify new scaffolds that bind to the palmitate pocket of TEADs and disrupt their interaction with YAP1. Time- and concentration-dependent studies with wild-type and mutant TEAD1–4 provided insight into their reaction rates and binding constants and established the compounds as covalent inhibitors of TEAD binding to YAP1. Binding pose hypotheses were generated by covalent docking revealing that the fragments and compounds engage lower, middle, and upper sub-sites of the palmitate pocket. Our fragments and compounds provide new scaffolds and starting points for the design of derivatives with improved inhibition potency of TEAD palmitoylation and binding to YAP1.